Table 3 Adverse events of the patients after treatment
Adverse events | Any | Grade 1 | Grade 2 | ≥ Grade 3 | ||||
|---|---|---|---|---|---|---|---|---|
No | (%) | No | (%) | No | (%) | No | (%) | |
Appetite loss | 24 | 57.1 | 19 | 45.2 | 5 | 11.9 | 0 | 0 |
Nausea | 23 | 54.8 | 19 | 45.2 | 4 | 9.5 | 0 | 0 |
Vomiting | 12 | 28.6 | 7 | 16.7 | 5 | 11.9 | 0 | 0 |
Diarrhea | 4 | 9.5 | 3 | 7.1 | 0 | 0 | 1 | 2.4 |
Neutropenia | 24 | 57.1 | 16 | 38.1 | 7 | 16.7 | 1 | 2.4 |
Thrombocytopenia | 25 | 59.5 | 12 | 28.6 | 13 | 31.0 | 0 | 0 |
Increased ALT | 9 | 21.4 | 9 | 21.4 | 0 | 0 | 0 | 0 |
Increased AST | 12 | 28.6 | 12 | 28.6 | 0 | 0 | 0 | 0 |
Hyperbilirubinemia | 16 | 38.1 | 16 | 38.1 | 0 | 0 | 0 | 0 |
Rash | 1 | 2.4 | 0 | 0 | 1 | 2.4 | 0 | 0 |
Fatigue | 13 | 31.0 | 9 | 21.4 | 4 | 9.5 | 0 | 0 |
Weight loss | 8 | 19.0 | 5 | 11.9 | 3 | 7.1 | 0 | 0 |
Peripheral neuropathy | 8 | 19.0 | 7 | 16.7 | 1 | 2.4 | 0 | 0 |